The Microbiome in Cancer and Autoimmunity - Part A

by Manisha Singh (Editor)

Overview

Microbiome in Cancer and Autoimmunity - Part A, Volume 394 offers a comprehensive exploration of the intricate relationship between the human microbiome and the development of cancer and autoimmune diseases. Delving into cutting-edge research and clinical insights, this groundbreaking work elucidates the role of microbial communities in influencing immune responses, disease pathways, and therapeutic outcomes. From deciphering the molecular mechanisms underlying microbiome-host interactions to unraveling the impact of dysbiosis on disease progression, the book provides a multifaceted analysis of the microbiome's pivotal role in cancer and autoimmunity.With contributions from leading experts in the field, this book serves as a pivotal resource for researchers, clinicians, and healthcare professionals seeking to understand and harness the therapeutic potential of the microbiome in combating cancer and autoimmune conditions. - Discusses the Interconnection of Microbiome with Cancer and Autoimmunity - Explores the complex relationship between the microbiome and the development, progression, and treatment of cancer and autoimmune diseases - Covers the Role of Microbial Communities, including Analysis of the composition, diversity, and functions of microbial communities in influencing cancer and autoimmune conditions - Delves into how the microbiome influences immune responses, inflammation, and immune tolerance in the context of cancer and autoimmunity

Product Details

ISBN-13:	9780443317071
Publisher:	Elsevier Science & Technology Books
Publication date:	07/01/2025
Series:	International Review of Cell and Molecular Biology , #394
Sold by:	Barnes & Noble
Format:	eBook
Pages:	277
File size:	8 MB

About the Author

Manisha Singh, PhD, is a trained human and mouse immunologist and during the last 10 years, she has specialized in cancer immunology. The main focus of her work has been to increase the efficacy and understand the molecular mechanisms of various cancer immunotherapies. She is serving as the principal investigator on a 2-year grant ($545,486), having been funded by the US Department of Defense. Dr. Singh's current research is focused on understanding the role of inflammation in immune suppression and resistance to immunotherapy in cancer. Recently, she has submitted the NIH-R01 grant in which she proposed to study the role of IL-1α in immunotherapy induced resistance. She has published 24 peer-reviewed articles and many abstracts in prestigious journals such as Nature Communication, Journal of Immunology, and Journal of Clinical Investigator. Her work has been cited by several prestigious, peer-reviewed, international journals.

Table of Contents

1. Introduction to Microbiomes in Health and DiseaseSantosh Kumar, Prachi Agrawal, Prachi Mendhey, Robins Kumar, Abhishek Dadsena, Prakash Kaushik and Subham Patel2. Microbiome Dysbiosis in CancerRoza Nurieva3. Role of Microbiomes in Cancer ProgressionSadhna Aggarwal4. Microbiome-Mediated Immune Modulation in Tumor MicroenvironmentAbishai Dominic5. Microbiome and Cancer ImmunotherapyShweta Dubey and Mohini Vig6. The Multipotential Effect of Microbiome in Lung Cancer Development and ProgressionSeyed Javad Moghaddam, Nastaran Karimi, Angélica Baca De Anda, Emre Aksan, Maria T. Grimaldo and Rachel Yang7. Role of microbiome in anti-CAR-T cell therapySalah-Eddine Bentebibel and Reham Abdel-Wahab

What People are Saying About This

From the Publisher

Edited by one of the best scientists in the field, this series presents the latest updates in the field